nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Bone mass density, fracture history, self-reported osteoporosis as proxy variables for estrogen and the risk of non-small-cell lung cancer—A population based cohort study, the HUNT study: Are proxy variables friends or faults?
|
Hatlen, Peter |
|
2013 |
81 |
1 |
p. 39-46 8 p. |
artikel |
2 |
Clinical applicability of staging small cell lung cancer according to the seventh edition of the TNM staging system
|
Jhun, Byung Woo |
|
2013 |
81 |
1 |
p. 65-70 6 p. |
artikel |
3 |
Complete metabolic response in a patient with repeatedly relapsed non-small cell lung cancer harboring ROS1 gene rearrangement after treatment with crizotinib
|
Bos, M. |
|
2013 |
81 |
1 |
p. 142-143 2 p. |
artikel |
4 |
Contents
|
|
|
2013 |
81 |
1 |
p. vii-viii nvt p. |
artikel |
5 |
C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLC
|
Uzunoglu, Faik Güntac |
|
2013 |
81 |
1 |
p. 123-129 7 p. |
artikel |
6 |
Diagnosis of recurrence and assessment of post-recurrence survival in patients with extracranial non-small cell lung cancer evaluated by 18F-FDG PET/CT
|
Jiménez-Bonilla, Julio F. |
|
2013 |
81 |
1 |
p. 71-76 6 p. |
artikel |
7 |
Does histology predict survival of advanced non-small cell lung cancer patients treated with platin-based chemotherapy? An analysis of the Eastern Cooperative Oncology Group Study E1594
|
Hoang, Tien |
|
2013 |
81 |
1 |
p. 47-52 6 p. |
artikel |
8 |
Editorial Board
|
|
|
2013 |
81 |
1 |
p. v- 1 p. |
artikel |
9 |
Efficacy and safety of weekly nab-paclitaxel plus carboplatin in patients with advanced non-small cell lung cancer
|
Satouchi, Miyako |
|
2013 |
81 |
1 |
p. 97-101 5 p. |
artikel |
10 |
Health-related quality of life after surgical treatment in patients with non-small cell lung cancer: A systematic review
|
Poghosyan, Hermine |
|
2013 |
81 |
1 |
p. 11-26 16 p. |
artikel |
11 |
Identification of novel mutations of TP53, ALK and RET gene in metastatic thymic squamous cell carcinoma and its therapeutic implication
|
Hu, Zhenli |
|
2013 |
81 |
1 |
p. 27-31 5 p. |
artikel |
12 |
Major changes in lung cancer over the last ten years in France: The KBP-CPHG studies
|
Locher, Chrystèle |
|
2013 |
81 |
1 |
p. 32-38 7 p. |
artikel |
13 |
Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer
|
Traynor, Anne M. |
|
2013 |
81 |
1 |
p. 138-141 4 p. |
artikel |
14 |
Prognostic significance of CD151 overexpression in non-small cell lung cancer
|
Kwon, Mi Jung |
|
2013 |
81 |
1 |
p. 109-116 8 p. |
artikel |
15 |
Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: A systematic review with meta-analysis
|
Meng, Daquan |
|
2013 |
81 |
1 |
p. 1-10 10 p. |
artikel |
16 |
Pulmonary adenocarcinomas with micropapillary component significantly correlate with recurrence, but can be well controlled with EGFR tyrosine kinase inhibitors in the early stages
|
Sumiyoshi, Shinji |
|
2013 |
81 |
1 |
p. 53-59 7 p. |
artikel |
17 |
Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: The CAPPA-2 study
|
Morabito, Alessandro |
|
2013 |
81 |
1 |
p. 77-83 7 p. |
artikel |
18 |
Randomized phase II trial of non-platinum induction or consolidation chemotherapy plus concomitant chemoradiation in stage III NSCLC patients: Mature results of the Spanish Lung Cancer Group 0008 study
|
Garrido, Pilar |
|
2013 |
81 |
1 |
p. 84-90 7 p. |
artikel |
19 |
Randomized phase II trial of uracil/tegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small-cell lung cancer: NJLCG 0601
|
Sugawara, Shunichi |
|
2013 |
81 |
1 |
p. 91-96 6 p. |
artikel |
20 |
Role of ultrasound-guided transbronchial biopsy in the diagnosis of peripheral pulmonary lesions
|
Fuso, Leonello |
|
2013 |
81 |
1 |
p. 60-64 5 p. |
artikel |
21 |
The largest UK single centre series using hypofractionated radical radiotherapy for NSCLC in the very elderly
|
McPartlin, A.J. |
|
2013 |
81 |
1 |
p. 144- 1 p. |
artikel |
22 |
Thymidylate synthase and ERCC1 as predictive markers in patients with pulmonary adenocarcinoma treated with pemetrexed and cisplatin
|
Lee, Seung Hyeun |
|
2013 |
81 |
1 |
p. 102-108 7 p. |
artikel |
23 |
Tumor-associated neutrophils and macrophages in non-small cell lung cancer: No immediate impact on patient outcome
|
Carus, Andreas |
|
2013 |
81 |
1 |
p. 130-137 8 p. |
artikel |
24 |
Vimentin expression predicts the occurrence of metastases in non small cell lung carcinomas
|
Dauphin, Maryline |
|
2013 |
81 |
1 |
p. 117-122 6 p. |
artikel |